SP
Sanjiv Patel (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $980K of RLAY (48,199 sh × $20.33, as filed), executed Aug 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.0M
shares × price, as filed
Last traded
Oct 7
Filed Oct 8
Median ADV $74.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
RLAYRecent filings
RLAYSALE
Relay Therapeutics, Inc.
View filing →
$872K48,199 sh × $18.10
Exec Oct 7
Filed Oct 8 · 5:29 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $913K
48,199 sh × $18.94
Exec Sep 8
Filed Sep 9 · 4:12 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $980K
48,199 sh × $20.33
Exec Aug 17
Filed Aug 18 · 4:17 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $944K
48,199 sh × $19.58
Exec Jul 7
Filed Jul 8 · 5:08 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $338K
43,168 sh × $7.82
Exec Jan 6
Filed Jan 7 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $435K
62,073 sh × $7.00
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $153K
42,740 sh × $3.57
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $127K
42,769 sh × $2.97
Exec Apr 23 2025
Filed Apr 24 2025 · 5:30 PM ET More filings →